Joel Greenblatt Buys 4, Sells 1 in 2nd Quarter

Author's Avatar
insider
Aug 15, 2022
Article's Main Image

Joel Greenblatt recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

Known for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including "The Little Book that Beats the Market." He is also an Adjunct Professor with Columbia Business School.

As of the latest 13F report, the guru’s equity portfolio contained 1104 stocks valued at a total of $3.11Bil. The top holdings were GSPY(8.01%), SPY(4.71%), and MSFT(1.67%).

According to GuruFocus data, these were

Joel Greenblatt (Trades, Portfolio)’s top five trades of the quarter.

Gotham Enhanced 500 ETF


During the quarter,

Joel Greenblatt (Trades, Portfolio) bought 2,169,746 shares of ARCA:GSPY for a total holding of 12,013,285. The trade had a 1.45% impact on the equity portfolio. During the quarter, the stock traded for an average price of $22.49.

On 08/15/2022, Gotham Enhanced 500 ETF traded for a price of $23.4789 per share and a market cap of $312.86Mil. The stock has returned -2.05% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Gotham Enhanced 500 ETF has a price-earnings ratio of 16.77 and a price-book ratio of 3.69.

S&P 500 ETF TRUST ETF


During the quarter,

Joel Greenblatt (Trades, Portfolio) bought 73,978 shares of ARCA:SPY for a total holding of 388,322. The trade had a 0.9% impact on the equity portfolio. During the quarter, the stock traded for an average price of $408.8.

On 08/15/2022, S&P 500 ETF TRUST ETF traded for a price of $428.86 per share and a market cap of $394.50Bil. The stock has returned -2.46% over the past year.

GuruFocus gives the ETF a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, S&P 500 ETF TRUST ETF has a price-earnings ratio of 20.29, a price-book ratio of 3.87, a price-earnings-to-growth (PEG) ratio of 2.44, a EV-to-Ebitda ratio of 15.24 and a price-sales ratio of 3.02.

The price-to-GF Value ratio is 0.00, earning the stock a GF Value rank of 6.

Exelon Corp


During the quarter,

Joel Greenblatt (Trades, Portfolio) bought 373,560 shares of NAS:EXC for a total holding of 433,836. The trade had a 0.54% impact on the equity portfolio. During the quarter, the stock traded for an average price of $47.02.

On 08/15/2022, Exelon Corp traded for a price of $46.7 per share and a market cap of $46.39Bil. The stock has returned 39.51% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, Exelon Corp has a price-earnings ratio of 17.23, a price-book ratio of 1.92, a price-earnings-to-growth (PEG) ratio of 7.52, a EV-to-Ebitda ratio of 8.53 and a price-sales ratio of 1.62.

The price-to-GF Value ratio is 1.89, earning the stock a GF Value rank of 1.

iShares Core S&P 500 ETF


The guru established a new position worth 42,001 shares in ARCA:IVV, giving the stock a 0.51% weight in the equity portfolio. Shares traded for an average price of $411.02 during the quarter.

On 08/15/2022, iShares Core S&P 500 ETF traded for a price of $431.14 per share and a market cap of $320.14Bil. The stock has returned -2.43% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, iShares Core S&P 500 ETF has a price-earnings ratio of 18.69 and a price-book ratio of 3.60.

ITeos Therapeutics Inc


Joel Greenblatt (Trades, Portfolio) reduced their investment in NAS:ITOS by 131,430 shares. The trade had a 0.39% impact on the equity portfolio. During the quarter, the stock traded for an average price of $23.86.

On 08/15/2022, ITeos Therapeutics Inc traded for a price of $25.4 per share and a market cap of $903.61Mil. The stock has returned 3.08% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, ITeos Therapeutics Inc has a price-earnings ratio of 3.26, a price-book ratio of 1.45, a EV-to-Ebitda ratio of 0.31 and a price-sales ratio of 1.97.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

Also check out:
    Rating:
    0 / 5 (0 votes)
    Author's Avatar
    WRITTEN BY

    Request A Demo

    Learn more about GuruFocus' key features, including All-In-One Screener, backtesting, 30-year financial, stock summary page, guru trades, insider trades, excel Add-in, google sheets and much more.

    GuruFocus Screeners

    Related Articles